The Central Laboratory was established in 2001 and is an important place for implementing scientific research projects, tackling key projects, and cultivating graduate students in our institute. After years of development, it has now become a comprehensive large-scale experimental institution integrating a scientific research public service platform, a key laboratory for male reproduction and genetics, and a cancer biotherapy center. At present, the laboratory has been relocated to the fourth, fifth, and eighth floors of the research and teaching building, with a total area of 3000 square meters and research equipment worth 12 million yuan; There are currently 15 full-time researchers, including 3 with senior professional titles, 7 with intermediate professional titles, and 5 with junior professional titles. There are also 5 postdoctoral fellows and 7 master's students currently studying.
Platform composition:
1. Research Public Service Platform
The scientific research public service platform is located on the fifth floor of the scientific research teaching building, covering an area of 1349.75 square meters. It is an open professional experimental technology service platform for doctors, graduate students, and researchers in the entire hospital. At present, the platform has a well-equipped molecular biology laboratory
The cellular biology laboratory, tissue morphology laboratory, and bacterial laboratory can ensure the smooth conduct of general experiments. And it can further meet the scientific research needs of clinical and laboratory personnel through instrument sharing between different floors of the research building. According to statistics, the platform currently accepts on average every year
More than 70 postdoctoral fellows, graduate students, and various researchers have conducted experiments related to over 50 research projects, providing strong support for our institute's application for various research projects, application for scientific and technological achievements, and publication of SCI articles.
2. Male Reproduction and Genetics Laboratory
The Male Reproduction and Genetics Laboratory was established in 2001 and was selected as a key laboratory in Shenzhen in 2006. In 2008, it was selected as a key laboratory in Guangdong Province. In the past five years, the research institute has focused on gene expression and regulation of spermatogenesis, molecular mechanisms of male infertility, and stem cell differentiation
Good achievements have been made in the genomics research of differentiation and urinary malignant tumors, undertaking more than 50 scientific research projects at all levels, including 3 sub projects of the National "863" Program, 1 sub project of the National Major Scientific Research Program, and 13 sub projects of the National Natural Science Foundation of China. He has published 70 SCl papers, some of which have been published in Cell, International renowned journals such as Nature Genetics, NatureBiochnoloqy, European Urology, PLoS Genetics, Bioloqy of Reproduction, HumanReproduction, and Molecular Human Reproduction; Editor in chief of one academic monograph: applied for 19 international and national invention patents, of which 5 have been authorized; Received 3 scientific research achievement awards, among which "Genomics Research and Translational Application of Urinary System Tumors" won the first prize of Shenzhen Natural Science in 2014 and the second prize of China Medical Science and Technology in 2014.
3. Tumor Biological Therapy Center
The Biological Therapy Center was established in March 2013. In May and June of the same year, it passed the GMP laboratory tests of the Shenzhen Center for Disease Control and Prevention and the Guangdong Provincial Food and Drug Administration, and officially began clinical treatment work in June. Biological therapy is the fourth new technology for cancer treatment after surgery, chemotherapy, and radiotherapy, representing a new direction of development in cancer treatment. The treatment projects gradually carried out by our center are ClK, NK, and DC cell-mediated anti-tumor biotherapy. The center has hired Professor Xia Jianchuan, a well-known expert in tumor immune cell therapy from Sun Yat sen University Cancer Hospital, as a consultant. It has a rigorous, united and enterprising team of cell therapy technology members who have rich experience in biological therapy and strong scientific research capabilities. In recent years, the team has published more than 100 papers, including 25 papers included in SCi, and has won more than 20 national, provincial and municipal scientific research projects.